Our Blog...Cholangio-what??

The Cholangiocarcinoma Foundation’s Blog has been home to a variety of content ranging from patient perspectives to updates on medical advancements. Contributors like patients Christy Landon and Bekki Slater, along with caregivers Dave Fleischer and Jessica Thomas, share news and personal anecdotes. The blog serves as a resource to get familiar with the work of the Foundation. Keep an eye out for new posts as together we explore the world of cholangiocarcinoma and the tireless work towards a cure!

We're always looking to share good news. If you have something you'd like to share, please reach out to Allison Deragon.

Monthly Scientific Update – July 2022 (Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures)

By Cholangiocarcinoma Foundation | July 1, 2022

Kelly Butler, Dr. Reham Abdel-Wahab A recent study in Precision Oncology examined the diverse genetic and molecular profiles of biliary tract cancers (BTCs). With an…

Governor’s Signature Brings Awareness to Rare Cancer

By Jennifer Weaver | June 24, 2022

COLUMBUS – Ohio Governor Mike DeWine signed into law this morning House Bill 537, legislation sponsored by State Representative Cindy Abrams (R-Harrison) to designate February…

🤚🏻 Five for Friday – 5 Ways to Support 21 Miles of Hope

By Jennifer Weaver | June 24, 2022

Home / Blog / In 2016, Jonathan Whiting lost his wife, Lori, to cholangiocarcinoma (CCA). He is swimming across the English Channel in July to…

Global patient registry to expand cholangiocarcinoma knowledge worldwide offered by Cholangiocarcinoma Foundation in partnership with Invitae

By Jennifer Weaver | June 23, 2022

Global patient registry to expand cholangiocarcinoma knowledge worldwide offered by Cholangiocarcinoma Foundation in partnership with Invitae  The Cholangiocarcinoma Foundation (CCF) in partnership with Invitae has…

5 Trials at ASCO 2022

By Reham Abdel-Wahab | June 17, 2022

Home / Blog / The American Society of Clinical Oncology (ASCO) meeting took place in Chicago the first week of June. The Foundation provided an…

Happy Retirement to Donna Mayer

By Jennifer Weaver | June 14, 2022

The Cholangiocarcinoma Foundation announces the retirement of Donna Mayer. Donna worked tirelessly to help build CCF into a trusted, global source of cholangiocarcinoma information and…

🤚🏻 Five for Friday – 5 CholangioConnect Resources

By Allison Deragon | June 10, 2022

Home / Blog / Through peer-to-peer mentorship with a fellow patient or caregiver, CholangioConnect is creating a community of hope. Please consider becoming a mentor and making…

🤚🏻 Five(+3) for Friday – 8 New Biomarker Stories

By Allison Deragon | June 3, 2022

Home / Blog / Biomarker testing opens doors to personalized treatment options, including clinical trials, for cancer patients. The Foundation is proud to present eight patient…

Bill recognizing Cholangiocarcinoma Awareness Day clears Ohio Senate, heads to governor

By Jennifer Weaver | June 2, 2022

The Cholangiocarcinoma Foundation congratulates Rep. Cindy Abrams (R-Harrison) and the Ohio legislature for the passage of House Bill 537. The legislation sponsored by Abrams designating…

Monthly Scientific Update – June 2022 (Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs. Resection for Patients With Multifocal Intrahepatic Cholangiocarcinoma)

By Reham Abdel-Wahab | June 1, 2022

The role of locoregional therapy in treating intrahepatic cholangiocarcinoma (iCCA) patients is still limited. Therefore, a group of researchers assessed if using a hepatic arterial…

🤚🏻 Five for Friday – 5 NCSD Activities that Celebrate Survivorship

By Cholangiocarcinoma Foundation | May 27, 2022

Home / Blog / June 5th is National Cancer Survivors Day (NCSD). This year marks the 35th Annual NCSD, which is a day for cancer…

🤚🏻 Five for Friday – 5 Episodes of Cholangio Heroes

By Jennifer Weaver | May 20, 2022

Home / Blog / The Foundation is pleased to announce its first-ever video podcast, Cholangio Heroes. A wide array of guests impacted by cholangiocarcinoma are featured…